TCA
TWST icon

Trifecta Capital Advisors’s Twist Bioscience TWST Stock Holding History

Trifecta Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.8K Buy
610
+135
+28% +$8.79K 0.01% 180
2026
Q1 		$22.6K Hold
475
– – ﹤0.01% 201
2025
Q4 		$15.1K Buy
+475
New +$14.8K ﹤0.01% 208

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Trifecta Capital Advisors's TWST Position: Q2 2026 in Review

Trifecta Capital Advisors increased its Twist Bioscience (TWST) stake by 28% in Q2 2026, buying an estimated $8.79K and bringing the position to 610 shares worth $62.8K. The position accounts for 0.01% of the portfolio, ranked #180.

Trifecta Capital Advisors first reported a position in TWST in Q4 2025 and has held it in 3 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Trifecta Capital Advisors held 610 shares of Twist Bioscience worth $62.8K as of Q2 2026.
  • Trifecta Capital Advisors bought 135 Twist Bioscience shares in Q2 2026, an estimated $8.79K.
  • Twist Bioscience made up 0.01% of Trifecta Capital Advisors's portfolio in Q2 2026, its #180 holding.
  • Trifecta Capital Advisors first reported a position in Twist Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.